The COVID-19 pandemic: an opportunity to make mental health a higher public health priority.

Coronavirus disease 2019 epidemiology mental health public health suicide

Journal

BJPsych open
ISSN: 2056-4724
Titre abrégé: BJPsych Open
Pays: England
ID NLM: 101667931

Informations de publication

Date de publication:
20 Sep 2021
Historique:
entrez: 20 9 2021
pubmed: 21 9 2021
medline: 21 9 2021
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19) was first recognised in December 2019. The subsequent pandemic has caused 4.3 million deaths and affected the lives of billions. It has increased psychosocial risk factors for mental illness including fear, social isolation and financial insecurity and is likely to lead to an economic recession. COVID-19 is associated with a high rate of neuropsychiatric sequelae. The long-term effects of the pandemic on mental health remain uncertain but could be marked, with some predicting an increased demand for psychiatric services for years to come. COVID-19 has turned a spotlight on mental health for politicians, policy makers and the public and provides an opportunity to make mental health a higher public health priority. We review longstanding reasons for prioritising mental health and the urgency brought by the COVID-19 pandemic, and highlight strategies to improve mental health and reduce the psychiatric fallout of the pandemic.

Identifiants

pubmed: 34538286
doi: 10.1192/bjo.2021.1002
pii: S2056472421010024
pmc: PMC8458855
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e172

Références

Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Child Adolesc Ment Health. 2021 May;26(2):157-166
pubmed: 33733620
Lancet Psychiatry. 2020 Jun;7(6):468-471
pubmed: 32330430
World Psychiatry. 2007 Oct;6(3):177-85
pubmed: 18188443
Br J Psychiatry. 2007 Mar;190:192-3
pubmed: 17329736
Lancet Psychiatry. 2021 Feb;8(2):130-140
pubmed: 33181098
BMC Public Health. 2016 Feb 03;16:115
pubmed: 26847554
Lancet. 2007 Sep 8;370(9590):841-50
pubmed: 17826169
World Psychiatry. 2021 Feb;20(1):124-130
pubmed: 33026219
BMC Fam Pract. 2012 Mar 16;13:19
pubmed: 22423592
EMBO Rep. 2016 Sep;17(9):1245-9
pubmed: 27491723
Curr Psychiatry Rep. 2020 Oct 8;22(12):66
pubmed: 33030637
Int J Environ Res Public Health. 2021 Mar 26;18(7):
pubmed: 33810225
Health Serv Insights. 2017 Mar 28;10:1178632917694350
pubmed: 28469456
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Lancet Reg Health Eur. 2021 Mar;2:100020
pubmed: 33870246
Lancet. 2007 Sep 8;370(9590):807-8
pubmed: 17826153
Curr Psychiatry Rep. 2020 Jul 10;22(8):43
pubmed: 32651717
Lancet Psychiatry. 2021 Jul;8(7):610-619
pubmed: 33965057
Nat Med. 2020 May;26(5):640-642
pubmed: 32273610
J Psychosom Res. 2014 Mar;76(3):175-92
pubmed: 24529036
Eur Neuropsychopharmacol. 2005 Aug;15(4):357-76
pubmed: 15961293
J Psychiatr Res. 2021 Apr;136:603-609
pubmed: 33138985
BMC Public Health. 2021 Jan 9;21(1):104
pubmed: 33422039

Auteurs

Javed Latoo (J)

Hamad Medical Corporation and College of Medicine, Qatar University, Doha, Qatar.

Peter M Haddad (PM)

Hamad Medical Corporation, College of Medicine, Qatar University, Doha, Qatar; and Manchester University, UK.

Minal Mistry (M)

Department of Psychiatry, Fredericton, New Brunswick, Canada.

Ovais Wadoo (O)

Hamad Medical Corporation, Doha, Qatar; and Middle East Division of the Royal College of Psychiatrists.

Sheikh Mohammed Shariful Islam (SMS)

National Health and Medical Research Council and Institute for Physical Activity and Nutrition, Deakin University, Melbourne, Australia.

Farida Jan (F)

Northamptonshire Healthcare NHS Foundation Trust, Northampton, UK.

Yousaf Iqbal (Y)

Hamad Medical Corporation, Doha, Qatar.

Tom Howseman (T)

St Luke's Primary Care Centre, Northamptonshire, UK.

David Riley (D)

Department of Palliative Care, Northamptonshire Healthcare NHS Foundation Trust, Northampton, UK.

Majid Alabdulla (M)

Department of Psychiatry, Hamad Medical Corporation, and College of Medicine, Qatar University, Doha, Qatar.

Classifications MeSH